Tommy G. Thompson Acquires 5,700 Shares of Healthpeak Properties, Inc. (NYSE:DOC) Stock

Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) Director Tommy G. Thompson acquired 5,700 shares of the company's stock in a transaction that occurred on Friday, May 9th. The shares were bought at an average price of $17.36 per share, with a total value of $98,952.00. Following the transaction, the director now owns 138,513 shares in the company, valued at $2,404,585.68. This represents a 4.29% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Healthpeak Properties Stock Up 1.2%

Shares of DOC traded up $0.21 during trading on Thursday, reaching $17.18. The company's stock had a trading volume of 2,365,306 shares, compared to its average volume of 4,969,787. The company has a fifty day moving average of $18.97 and a two-hundred day moving average of $20.17. Healthpeak Properties, Inc. has a twelve month low of $16.90 and a twelve month high of $23.26. The company has a market cap of $11.93 billion, a price-to-earnings ratio of 49.02, a P/E/G ratio of 2.17 and a beta of 1.05. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The company had revenue of $702.89 million for the quarter, compared to analyst estimates of $690.76 million. During the same period in the prior year, the company posted $0.45 EPS. Healthpeak Properties's quarterly revenue was up 15.9% on a year-over-year basis. On average, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently declared a dividend, which was paid on Wednesday, April 30th. Investors of record on Friday, April 18th were given a dividend of $0.1017 per share. This represents a dividend yield of 6.5%. The ex-dividend date was Thursday, April 17th. Healthpeak Properties's dividend payout ratio is currently 305.00%.

Institutional Investors Weigh In On Healthpeak Properties

Institutional investors and hedge funds have recently made changes to their positions in the company. Barclays PLC bought a new position in Healthpeak Properties during the 3rd quarter worth $35,078,000. Franklin Resources Inc. bought a new position in Healthpeak Properties during the 3rd quarter worth $3,224,000. Principal Financial Group Inc. bought a new position in shares of Healthpeak Properties in the third quarter worth $18,736,000. JPMorgan Chase & Co. grew its stake in shares of Healthpeak Properties by 23.2% in the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock worth $493,115,000 after purchasing an additional 4,056,931 shares in the last quarter. Finally, Harbor Capital Advisors Inc. grew its stake in shares of Healthpeak Properties by 5.4% in the fourth quarter. Harbor Capital Advisors Inc. now owns 23,074 shares of the real estate investment trust's stock worth $468,000 after purchasing an additional 1,186 shares in the last quarter. 93.57% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DOC has been the subject of several recent analyst reports. Argus restated a "buy" rating and issued a $25.00 price target on shares of Healthpeak Properties in a report on Tuesday, April 29th. StockNews.com cut Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Thursday, May 1st. Scotiabank lowered their price target on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a report on Monday. Wedbush lowered their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Finally, Robert W. Baird reduced their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $23.25.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.